acut
respiratori
tract
infect
ari
main
caus
morbid
mortal
children
worldwid
estim
death
occur
children
less
year
old
due
pneumonia
mexico
ari
lead
caus
diseas
first
multiplex
pcr
assay
respiratori
virus
approv
us
fda
xtagrvp
tm
luminex
mexico
indr
nation
refer
institut
diagnosi
use
method
detect
respiratori
virus
howev
cost
high
special
infrastructur
need
anyplex
tm
ii
introduc
mexico
access
cost
kit
approv
european
commun
novemb
canadian
depart
health
juli
korea
fda
diagnosi
respiratori
virus
aim
studi
compar
two
multiplex
pcr
techniqu
detect
respiratori
virus
sampl
children
pneumonia
march
august
sampl
includ
children
month
year
old
clinic
radiolog
diagnosi
pneumonia
admit
six
differ
hospit
mexico
written
inform
consent
parent
guardian
nasal
wash
obtain
children
use
salin
solut
instil
nostril
use
cathet
aspir
dilut
viral
cultur
media
aliquot
store
c
process
one
aliquot
sent
indr
viral
detect
xtagrvp
anoth
aliquot
process
simultan
anyplex
ii
faculti
medicin
unam
gold
standard
construct
result
techniqu
discrep
sequenc
viru
frequenc
sensit
specif
posit
neg
predict
valu
kappa
coeffici
calcul
total
sampl
posit
viru
either
techniqu
use
xtagrvp
overal
frequent
detect
virus
rsva
rhinovirusenteroviru
parainfluenza
virus
adenoviru
comparison
method
show
differ
detect
rsva
rhinovirusenteroviru
metapneumoviru
adenoviru
tabl
assay
detect
virus
one
sampl
one
viru
sampl
one
sampl
contrast
xtagrvp
detect
virus
one
sampl
one
viru
sampl
one
sampl
result
obtain
two
techniqu
show
discrep
sampl
sequenc
gold
standard
construct
made
determin
diagnost
perform
test
overal
xtagrvp
similar
sensit
vs
respect
p
specif
vs
respect
p
posit
predict
valu
vs
p
neg
predict
valu
vs
p
howev
individu
virus
statist
signific
differ
observ
sensit
xtagrvp
adenoviru
vs
p
rsva
vs
p
addit
show
higher
specif
metapneumoviru
detect
compar
xtagrvp
p
kappa
coeffici
percentag
agreement
vari
wide
tabl
studi
compar
sensit
specif
detect
respiratori
virus
xtagrvp
overal
two
test
similar
perform
howev
signific
differ
sensit
observ
rsva
adenoviru
detect
adenoviru
repres
signific
challeng
serotyp
lower
detect
certain
adenoviru
serotyp
use
xtagrvp
report
overal
sensit
studi
also
shown
lower
sensit
xtagrvp
compar
adenoviru
detect
one
advantag
compar
xtagrvp
abil
detect
human
bocaviru
anoth
advantag
better
capac
detect
coinfect
higher
number
virus
one
sampl
conclus
xtagrvp
show
similar
diagnost
perform
nevertheless
scenario
rsva
adenoviru
human
bocaviru
import
caus
infect
may
provid
favor
result
evalu
clinic
set
sampl
type
would
help
guid
select
best
suit
multiplex
pcr
kit
diagnost
purpos
work
support
part
grant
wongchew
rm
santospreciado
ji
consejo
nacion
de
ciencia
conacyt
apgr
recipi
scholarship
conacyt
grant
